New Zealand markets close in 3 hours 58 minutes

Merck & Co., Inc. (MRK.BA)

Buenos Aires - Buenos Aires Delayed price. Currency in ARS
Add to watchlist
28,635.50-23.50 (-0.08%)
At close: 05:00PM ART
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
Total revenue
60,115,000
60,115,000
59,283,000
48,704,000
41,518,000
Cost of revenue
16,126,000
16,126,000
17,411,000
13,626,000
13,618,000
Gross profit
43,989,000
43,989,000
41,872,000
35,078,000
27,900,000
Operating expenses
Research development
30,531,000
30,531,000
13,548,000
12,245,000
13,397,000
Selling general and administrative
10,504,000
10,504,000
10,042,000
9,634,000
8,955,000
Total operating expenses
41,035,000
41,035,000
23,590,000
21,879,000
22,352,000
Operating income or loss
2,954,000
2,954,000
18,282,000
13,199,000
5,548,000
Interest expense
1,146,000
1,146,000
962,000
806,000
831,000
Total other income/expenses net
-284,000
-284,000
-1,033,000
1,450,000
1,087,000
Income before tax
1,889,000
1,889,000
16,444,000
13,879,000
5,863,000
Income tax expense
1,512,000
1,512,000
1,918,000
1,521,000
1,340,000
Income from continuing operations
377,000
377,000
14,526,000
12,358,000
4,523,000
Net income
365,000
365,000
14,519,000
13,049,000
7,067,000
Net income available to common shareholders
365,000
365,000
14,519,000
13,049,000
7,067,000
Basic EPS
18.10
1.40
57.30
51.60
27.93
Diluted EPS
18.00
1.40
57.10
51.40
27.80
Basic average shares
253,725
253,700
253,200
253,000
253,023
Diluted average shares
254,875
254,700
254,200
253,800
254,100